{"id":12229,"date":"2025-01-14T17:29:26","date_gmt":"2025-01-14T16:29:26","guid":{"rendered":"https:\/\/valintermed.com\/?p=12229"},"modified":"2025-01-14T17:29:26","modified_gmt":"2025-01-14T16:29:26","slug":"neyromielit-opticheskiy","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/optic-neuromyelitis-2\/","title":{"rendered":"Neuromyelitis opticus"},"content":{"rendered":"
<\/div>\n

Neuromyelitis optica (NMO), or NMO syndrome, is a demyelinating disease of the central nervous system characterized by inflammation and damage to the myelin sheath of the optic nerves and spinal cord. The condition can cause severe neurological deficits, including vision loss and paralysis, but its clinical manifestations can vary greatly. Neuromyelitis optica is classified as an autoimmune disease, in which the body's own antibodies attack the tissues of the nervous system. Importantly, NMO typically manifests in episodes of contamination and remission, with repeated attacks possibly leading to increasing functional deficits.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n